한글목차

개요

경피 약물전달 시장은 2023-2028년간 24억 4,000만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 4.9%를 나타낼 것으로 예측됩니다.

경피 약물전달 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 만성질환의 만연, 경피 패치의 용도 확대, 경피 약물전달을 위한 생분해성/생체 적합성 재료 등이 시장 성장을 가속하고 있습니다.

본 조사에서는 향후 몇 년간 경피 약물전달 시장 성장을 가속하는 주요인 중 하나로서 경피에 관한 의약품에 대한 관심 증가를 들고 있습니다. 비침습적 치료에 대한 큰 수요, 사업 확대을 위한 공동 연구에 대한 주목 증가 또한 시장의 높은 수요로 연결될 전망입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 경피 약물전달 시장(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 유형별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 진통제 : 시장 규모와 예측(2023-2028년)
• 신경질환 : 시장 규모와 예측(2023-2028년)
• 호르몬 대체요법 : 시장 규모와 예측(2023-2028년)
• 심혈관질환 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제7장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 경피 패치 : 시장 규모와 예측(2023-2028년)
• 경피 반고체 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유형별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 프랑스 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• 3M Co.
• Boehringer Ingelheim International GmbH
• Croda International Plc
• Hisamitsu Pharmaceutical Co. Inc.
• Johnson and Johnson
• Kindeva Drug Delivery L.P.
• Luye Pharma Group Ltd.
• Medherant Ltd.
• Novartis AG
• ProSolus Inc.
• Purdue Pharma LP
• Radius Health Inc.
• Teikoku Seiyaku Co. Ltd.
• UCB SA
• Viatris Inc.

제13장 부록

영문목차

Abstract

The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

Technavio's transdermal drug delivery market is segmented as below:

By Application

• Analgesics
• Neurological disorders
• Hormone replacement therapy
• Cardiovascular disorders
• Others

By Type

• Transdermal patches
• Transdermal semisolids

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

• Transdermal drug delivery market sizing
• Transdermal drug delivery market forecast
• Transdermal drug delivery market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global transdermal drug delivery market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Analgesics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)
• 6.4 Neurological disorders - Market size and forecast 2023-2028
• Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)
• 6.5 Hormone replacement therapy - Market size and forecast 2023-2028
• Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
• 6.6 Cardiovascular disorders - Market size and forecast 2023-2028
• Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Application
• Exhibit 54: Market opportunity by Application ($ billion)
• Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 56: Chart on Type - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 58: Chart on Comparison by Type
• Exhibit 59: Data Table on Comparison by Type
• 7.3 Transdermal patches - Market size and forecast 2023-2028
• Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)
• 7.4 Transdermal semisolids - Market size and forecast 2023-2028
• Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 68: Market opportunity by Type ($ billion)
• Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share by geography 2023-2028 (%)
• Exhibit 72: Data Table on Market share by geography 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.10 France - Market size and forecast 2023-2028
• Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
• Exhibit 111: Market opportunity by geography ($ billion)
• Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 3M Co.
• Exhibit 119: 3M Co. - Overview
• Exhibit 120: 3M Co. - Business segments
• Exhibit 121: 3M Co. - Key news
• Exhibit 122: 3M Co. - Key offerings
• Exhibit 123: 3M Co. - Segment focus
• 12.4 Boehringer Ingelheim International GmbH
• Exhibit 124: Boehringer Ingelheim International GmbH - Overview
• Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 126: Boehringer Ingelheim International GmbH - Key news
• Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
• 12.5 Croda International Plc
• Exhibit 129: Croda International Plc - Overview
• Exhibit 130: Croda International Plc - Business segments
• Exhibit 131: Croda International Plc - Key news
• Exhibit 132: Croda International Plc - Key offerings
• Exhibit 133: Croda International Plc - Segment focus
• 12.6 Hisamitsu Pharmaceutical Co. Inc.
• Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
• Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
• Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
• 12.7 Johnson and Johnson
• Exhibit 137: Johnson and Johnson - Overview
• Exhibit 138: Johnson and Johnson - Business segments
• Exhibit 139: Johnson and Johnson - Key news
• Exhibit 140: Johnson and Johnson - Key offerings
• Exhibit 141: Johnson and Johnson - Segment focus
• 12.8 Kindeva Drug Delivery L.P.
• Exhibit 142: Kindeva Drug Delivery L.P. - Overview
• Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service
• Exhibit 144: Kindeva Drug Delivery L.P. - Key news
• Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings
• 12.9 Luye Pharma Group Ltd.
• Exhibit 146: Luye Pharma Group Ltd. - Overview
• Exhibit 147: Luye Pharma Group Ltd. - Business segments
• Exhibit 148: Luye Pharma Group Ltd. - Key offerings
• Exhibit 149: Luye Pharma Group Ltd. - Segment focus
• 12.10 Medherant Ltd.
• Exhibit 150: Medherant Ltd. - Overview
• Exhibit 151: Medherant Ltd. - Product / Service
• Exhibit 152: Medherant Ltd. - Key offerings
• 12.11 Novartis AG
• Exhibit 153: Novartis AG - Overview
• Exhibit 154: Novartis AG - Business segments
• Exhibit 155: Novartis AG - Key offerings
• Exhibit 156: Novartis AG - Segment focus
• 12.12 ProSolus Inc.
• Exhibit 157: ProSolus Inc. - Overview
• Exhibit 158: ProSolus Inc. - Product / Service
• Exhibit 159: ProSolus Inc. - Key offerings
• 12.13 Purdue Pharma LP
• Exhibit 160: Purdue Pharma LP - Overview
• Exhibit 161: Purdue Pharma LP - Product / Service
• Exhibit 162: Purdue Pharma LP - Key offerings
• 12.14 Radius Health Inc.
• Exhibit 163: Radius Health Inc. - Overview
• Exhibit 164: Radius Health Inc. - Product / Service
• Exhibit 165: Radius Health Inc. - Key offerings
• 12.15 Teikoku Seiyaku Co. Ltd.
• Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview
• Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service
• Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings
• 12.16 UCB SA
• Exhibit 169: UCB SA - Overview
• Exhibit 170: UCB SA - Product / Service
• Exhibit 171: UCB SA - Key offerings
• 12.17 Viatris Inc.
• Exhibit 172: Viatris Inc. - Overview
• Exhibit 173: Viatris Inc. - Business segments
• Exhibit 174: Viatris Inc. - Key news
• Exhibit 175: Viatris Inc. - Key offerings
• Exhibit 176: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations